Success Metrics

Clinical Success Rate

71.4%

Based on 5 completed trials

Completion Rate

71%(5/7)

Active Trials

0(0%)

Results Posted

60%(3 trials)

Terminated

2(25%)

Phase Distribution

Ph not_applicable

38%

Ph early_phase_1

13%

Ph phase_2

25%

Ph phase_1

13%

Ph phase_3

13%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Early Phase 1First-in-human

1(12.5%)

Phase 1Safety & dosage

1(12.5%)

Phase 2Efficacy & side effects

2(25.0%)

Phase 3Large-scale testing

1(12.5%)

N/ANon-phased studies

3(37.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Terminated(2)

Other(1)

Detailed Status

Completed5

Terminated2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

71.4%

Most Advanced

Phase 3

Trials by Phase

Early Phase 11 (12.5%)

Phase 11 (12.5%)

Phase 22 (25.0%)

Phase 31 (12.5%)

N/A3 (37.5%)

Trials by Status

completed563%

unknown113%

terminated225%

Recent Activity

0 active trials

Showing 5 of 8

completednot_applicable

Human Transdermal Vitamin D Supplement Study

NCT06098846

completednot_applicable

Tulobuterol Patch in Pediatric Patients Undergoing Tonsillectomy

NCT04057469

completedphase_2

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

NCT02312934

completedearly_phase_1

Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women

NCT02042196

terminatednot_applicable

Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients

NCT01602198

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT06098846Not Applicable

Human Transdermal Vitamin D Supplement Study

Completed

NCT04057469Not Applicable

Tulobuterol Patch in Pediatric Patients Undergoing Tonsillectomy

Completed

NCT02312934Phase 2

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

Completed

NCT02042196Early Phase 1

Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women

Completed

NCT01602198Not Applicable

Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients

Terminated

NCT00315458Phase 3

Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.

Terminated

NCT00108810Phase 2

Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee

Completed

NCT00091468Phase 1

Nicotine Treatment of Mild Cognitive Impairment (MCI)

Unknown

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8